Lixte Biotechnology Holdings Inc
NASDAQ:LIXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Luotea Oyj
OMXH:LUOTEA
|
FI |
|
Isofol Medical AB (publ)
STO:ISOFOL
|
SE |
During the last 3 months Lixte Biotechnology Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/lixt/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 3, 2023
by
Bernards Rene
, who
bought
13.9k USD
worth of
LIXT shares.
During the last 3 months Lixte Biotechnology Holdings Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/lixt/vs/indx/gspc">open performance analysis).
The last transaction was made on
Oct 3, 2023
by
Bernards Rene
, who
bought
13.9k USD
worth of
LIXT shares.
Lixte Biotechnology Holdings Inc
Glance View
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. The company is headquartered in East Setauket, New York and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two categories of compounds at various stages of pre-clinical and clinical development that has the therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The firm has developed two series of pharmacologically active drugs, the LB-100 series and the LB-200 series. The LB-100 series consists of structures, which is treated not only several types of cancer but also vascular and metabolic diseases. The LB-200 series contains compounds, which are useful for the treatment of chronic hereditary diseases.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.